Australia's largest stock trading and investment forum Australia's #1 stock forum

BNO

Click for more information

5.26%

20.0¢ bionomics limited

Technical Breakdown, page-7

First 7 Last

Share
Profile

Follow
Domesticgod

740 Posts.

64

15/08/18

19:19

Post #: 34961196
Share

Originally posted by doubledeckerdog ↑

It is never too early to call time on an under-performing CEO - she has not delivered sustainable value for shareholders in the 15 plus years we have been over paying her.

I think a clinical disappointment now terminate her rather long stay at the trough.

Perhaps Merck can pick up the full tab for her overpriced services for another decade - because I do not think shareholders in Bionomics should.

Her undoubted hard work of talking and globetrotting have done nothing for me and most other long term holders of this stock.

Lots of promise but no real money to show for it.

The only real financial beneficiaries of this company have been the CEO and executives.

Lets get it over with.....................

Expand

Blimey- I thought this was a post for Starpharma when I first read it!
There are great similarities between the two CEO's so I will be watching closely what happens to yours...

BNO Price at posting: 46.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

AXP

Tambourah chases gold veins and mineralisation extension with drilling

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 4 more messages in this thread...

First 7 Last

Add BNO (ASX) to my watchlist

SPONSORED BY